Unique Complications of Monochorionic Twins: Diagnosis and Management  by Chang, Yao-Lung
1©Elsevier & CTSUM. All rights reserved. J Med Ultrasound 2007 • Vol 15 • No 1
Introduction
Twins account for 10% of perinatal mortality,
although they represent only 3.0% of pregnancies
[1]. Twin pregnancy has a more complicated course
in utero than singletons, and management is also
complicated by the fact that more than one fetus
must be taken into account. Approximately 30% of
twins are monozygotic and 70% are dizygotic [2].
The key to management of multiple pregnancies 
is the accurate determination of chorionicity. This is
best performed in the first trimester when accuracy
rates approach 100% [3]. If monochorionic (MC)
twins have been confirmed, then some unique com-
plications mentioned in this article should be kept
in mind before performing sonographic examina-
tion. These complications include twin–twin trans-
fusion syndrome (TTTS), twin reversed arterial
perfusion (TRAP), MC twins with selective intrauter-
ine growth restriction (IUGR), and MC twins with
one anomaly.
Common obstetric complications, such as
preeclampsia, gestational diabetes, preterm labor,
and intrauterine fetal growth restriction, occur more
frequently in multiple gestations, yet the diagnosis
and management of these conditions are similar to
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those in singleton pregnancies [4]. MC twins run
the highest risk of complications and the wellbeing
of one fetus crucially depends on that of the other
because of the almost ever-present vascular anasto-
moses in the common placenta [3]. Management of
the unique complications of MC twins are also influ-
enced by the vascular anastomoses on the chorionic
plate. These complications include TTTS, TRAP, IUGR,
and MC twins with one anomaly. Diagnosis of
these unique complications of MC twin pregnancy
depend heavily on ultrasonography, and manage-
ment would largely be dependent on the sono-
graphic guide procedures.
TTTS
The etiology of TTTS appears to result from a net
unbalanced flow of blood between two MC fetuses
through placental vascular communications, which
results in a donor twin and a recipient twin. Although
actual documentation of the unbalanced blood flow
remains elusive [5], vascular anastomoses might be
responsible for the development of TTTS if the vas-
cular design is such that it forces a net flow from
donor to recipient [5]. Alternatively, vascular anas-
tomoses might play a passive role in the develop-
ment of the syndrome, but nonetheless allow its
development. This is the case with MC twins who
are discordant for congenital heart disease, cardio-
myopathies, cord anomalies, or other conditions
associated with uneven hemodynamic competence
[6]. When the onset of this condition occurs before
26 weeks of gestation, there is a significant associ-
ated risk of fetal loss, perinatal death, and subse-
quent handicap in survivors [7]. If untreated at its
early onset, severe TTTS has a dismal prognosis,
with perinatal mortality rates > 90% [8], and > 30%
of survivors suffering from associated neurodevel-
opmental anomalies [8].
Diagnosis
The diagnosis of TTTS is based on the following
sonographic findings: (1) polyhydramnios, ≥8cm of
maximum vertical pocket (MVP) in the recipient
twin; (2) oligohydramnios, MVP ≤ 2 cm in the donor
twin; (3) single placenta, thin dividing membrane,
and similar external genitalia.
In a study of 178 twin pairs [9], only four pairs
had a hemoglobin difference > 5 g/dL and a weight
difference > 20%, and none of those pregnan-
cies showed evidence of polyhydramnios or oligo-
hydramnios. Similarly, percutaneous umbilical
blood sampling in six TTTS patients failed to show
hemoglobin differences > 5 g/dL, except in one
pregnancy [10]. Consequently, the previous pedi-
atric criteria of a hemoglobin difference > 5 g/dL
and a weight difference > 20% are no longer appli-
cable [6].
The severity of TTTS depends on several prog-
nostic factors, the most important of which is the
Doppler flow of the two involved fetuses; the most
widely used criteria for TTTS staging is that of
Quintero et al [11], which is as follows:
• Stage I — the bladder of the donor twin is still
visible, and Doppler studies are still normal;
• Stage II — the bladder of the donor twin is not
visible (during the length of the examination,
usually 1 hour), but Doppler studies are not crit-
ically abnormal;
• Stage III — Doppler studies are critically abnormal
in either twin and are characterized as absent or
reverse end-diastolic velocity in the umbilical
artery, reverse flow in the ductus venosus, or
pulsatile umbilical venous flow;
• Stage IV — presence of ascites, pericardial or
pleural effusion, scalp edema, or overt hydrops;
• Stage V — demise of one or both fetuses.
There were about 80 cases of TTTS predicted to
occur each year in Taiwan [12]; half of them would
be the severe form (diagnosed before gestational
age of 26 weeks). So familiarity with the diagnostic
criteria of TTTS would be necessary for medics
who would possibly manage the high-risk multiple
pregnancy.
Management
Undoubtedly, the most controversial aspect of TTTS
is treatment [6]. Interpretation of published thera-
peutic results must be done with caution because
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not all investigators have adhered to standard diag-
nostic sonographic criteria [6]. Treatment options
include serial amniocentesis, laser therapy, umbilical
cord occlusion, and septostomy.
Serial amniocentesis and endoscopic laser 
ablation of vascular anastomoses have both been
shown to reduce perinatal mortality in an uncon-
trolled series [13]. After the first and only random-
ized trial on interventions for TTTS was published,
comparing laser to amnioreduction [14], it was
proved that the laser group had a higher likelihood
of survival of at least one twin to 28 days of age
(76% vs. 56%; relative risk of the death of both
fetuses, 0.63; 95% confidence interval, 0.25–0.93;
p = 0.009) and to 6 months of age (p = 0.002) [14].
Recently, a clinical trial was conducted to compare
the efficacy of septostomy and amnioreduction in
treating TTTS [15], and the conclusion was that
septostomy and amnioreduction were equally effi-
cacious for early onset TTTS. But later, there were
differing comments about the conclusion of this
paper [16]. So in addition to laser therapy and
serial amnioreduction, I will also introduce the
method of septostomy in this section.
Serial amniocentesis
Serial amniocentesis could also be called amniore-
duction. The goal of this therapy is to decrease the
likelihood of miscarriage or preterm labor by reduc-
ing the amniotic fluid volume in the sac of the
recipient twin [6]. There is no standard technique
for performing serial amniocentesis. How much fluid
should be removed, at what rate, what needle, or
what type of anesthesia should be used are among
the issues that could benefit from standardization [6].
In Chang Gung Memorial Hospital, we only perform
serial amniocentesis in cases of TTTS with gestational
age ≥27 weeks. The patients treated by serial amnio-
centesis before this have been reported to have had
14% cases of leukomalacia in the surviving fetuses
and 76% risk of death of both fetuses [14]. So amnio-
reduction is not considered as the first line of therapy
for TTTS diagnosed before 26 weeks of gestation.
Sonography is very important in the procedure of
amnioreduction, because you need to evaluate the
position of the placenta, the position of the recip-
ient, and the amount of amniotic fluid before and
after this procedure.
Laser therapy
Fetoscopic laser therapy for TTTS performed percuta-
neously before 26 weeks of gestation is a minimally
invasive treatment with few maternal complications,
with premature rupture of membranes becoming
the main source of neonatal complications [17]. 
It has been recognized that laser surgery for TTTS
should be available in fetal medicine units that 
are managing at least 20 cases per year [13].
Sonography is very important before, during, and
after this procedure. Before the procedure, you
have to locate the position of the placenta, the
position of the fetuses, the amount of amniotic fluid,
and the ideal position for insertion of the fetoscope.
A good evaluation is crucial for a successful opera-
tion. The insertion of the fetoscope is usually not
difficult in mainly posterior placenta (Fig. 1); you
just need to choose the site of entry directly into
the sac of the recipient. The risk of septostomy is
low in such cases. But in cases of mainly anterior
placenta (Fig. 2), to choose an ideal site for entry is
not always easy. In cases where the free space for
entry is located near the sac of the donor, the risk
of septostomy is high. During operation, you have
to identify whether there are uterine wall vessels
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Fig. 1. Mainly posterior wall placenta, the 0 degree fetoscope
can be inserted to see the placenta directly.
on the site that you choose for entry so as to avoid
bleeding caused by trocar insertion. Because the
laser therapy for TTTS is usually one-port surgery,
the location of the fetoscope needs to be identified
by continuous sonographic monitoring. The uterine
cavity space is not so large in midtrimester even in
cases of polyhydramnios and multiple pregnancies.
The fetoscope could easily touch the uterine wall if
it is not monitored by sonography and there will be
a loss of the visual field in the endoscope. In extreme
conditions and unfamiliar hands, the fetoscope
could leave the uterine cavity unintentionally. At the
end of laser therapy, amnioreduction to reduce MVP
to below 8 cm is still performed under sonographic
guidance.
Umbilical cord occlusion
The goal of the umbilical cord occlusion technique
is to stop blood exchange between the fetuses at the
level of the umbilical cord of one of the twins; the
procedure is reserved for severe cases in which spon-
taneous fetal death of one of the twins is likely to
happen, particularly in the presence of hydrops or
intracranial hemorrhage found in one fetus [6].
Septostomy
In 1998, Saade et al [18] proposed the concept of
intentionally perforating the intertwin membrane
(septostomy) to allow equilibration of the amniotic
fluid volume in severe cases of TTTS. Indeed, allow-
ing the donor twin to swallow excess amniotic fluid
produced by the recipient is one explanation for the
extreme rarity of TTTS in monoamniotic twins. The
procedure is done by using a 22-gauge needle to
perforate the intertwin membrane with a single
puncture under ultrasound guidance. This is usually
introduced through the donor twin’s gestational
sac into the recipient twin’s amniotic cavity. If the
needle was introduced from the recipient’s sac, it
would be harder to puncture the donor’s sac due to
oligohydramnios and there is a risk of hurting the
donor. In view of the lack of mathematically or
clinically evidenced benefit of septostomy vs. amnio-
reduction and the significant risk of cord entang-
lement, amnioreduction but not septostomy should
be the continued procedure of choice after the
occurrence of fetal viability (at which time laser ther-
apy is generally not offered) [16].
TRAP
The TRAP sequence is a rare complication of
monozygotic multiple gestations that affects 1%
of monozygotic twins or 1 in 35,000 births [19].
The pathophysiologic mechanism that is responsi-
ble for the syndrome is not well known [20]; it has
been hypothesized that blood is perfused by the
hemodynamically advantaged twin (‘’pump’’ twin)
into the other twin (‘’acardiac’’ twin) by means of
retrograde blood flow through an arterioarterial and
a venovenous anastomosis in a MC placenta [20].
Thus, the acardiac twin receives deoxygenated
arterial blood from the pump twin. This inadequate
perfusion of the acardiac twin is responsible for a
spectrum of characteristic and invariably lethal set of
anomalies, which include acardia, acephalus, severe
maldevelopment of the upper body, variable limb
and organ reductions, malformations, and a relative
excess of edematous connective tissue [21].
Diagnosis
The prenatal diagnosis of acardiac twins should be
suspected when a grossly malformed fetus is seen
in the setting of a MC twin pregnancy (Fig. 3) [22].
Features visualized on ultrasound that point to the
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Fig. 2. Mainly anterior placenta, the 30 degree reverse scope
needs to be inserted to see the vascular anastomoses.
diagnosis include biometric discordance between
the twins, the absence of identifiable cardiac pulsa-
tion in one twin, poor definition of the head, trunk,
and upper extremities, deformed lower extremi-
ties, marked and diffuse subcutaneous edema, and
abnormal cystic areas in the upper part of the body
of the affected twin. The presence of cardiac motion
does not exclude the diagnosis, as it may result from
a rudimentary heart or transmitted pulsation from
the cardiac function of the pump twin. Retrograde
perfusion from the pump twin to the acardiac twin
is the key point for diagnosis of TRAP (Fig. 4).
Management
Management of TRAP should be tailored [23]. The
classification of TRAP has been done mainly accord-
ing to the prognostic factors [24], but even in the
same stage of the classification system, character-
istics including the flow amount and diameter of the
vessel of the communicating flow between the TRAP
and acardiac twin are different. The criteria for sur-
gery are: (1) abdominal circumference of the acar-
diac twin is equal to or greater than that of the
pump twin (i.e. acardiac/pump twin ratio ≥ 1.0;
the measurement is taken at the level of the stom-
ach including the skin); (2) polyhydramnios
(MVP ≥ 8 cm); (3) critically abnormal Doppler stud-
ies in the pump twin (persistent absent or reversed
diastolic blood flow in the umbilical artery, pulsatile
blood flow in the umbilical vein, and/or reversed
blood flow in the ductus venosus); (4) fetal hydrops
of the pump twin, defined as ≥ 2 fetal compart-
ments with fluid; and (5) monoamniotic twins
(high risk for cord entanglement) [21]. In a review
paper [24], intrafetal laser was chosen as the best
management for TRAP. But further publications
[21,24,25] showed that fetoscopic guide therapy
is also effective in such cases and many more cases
were studied in those papers compared to the pre-
vious study. The first successful umbilical cord liga-
tion of a TRAP twin in 1994 using custom-designed
instruments and combined endoscopic and ultra-
sound guidance was done by Quintero et al [26].
Recently, Quintero et al [21] analyzed 74 cases of
TRAP in a single institution and suggested that
patients with TRAP sequence who are treated with
umbilical cord occlusion have a more favorable
outcome relative to surgical candidates who do not
undergo surgery, provided that the dividing mem-
brane is not disrupted. That is because if the dividing
membrane is disrupted, the risk of cord accident
and ruptures of membrane would increase.
Selective IUGR
MC twins with selective IUGR of one twin was
defined as an estimated fetal weight below the
10th percentile for gestational age [27].
Selective IUGR of one twin usually presents as 
a large and small twin with significant discordant
sizes; they are MC same as in TTTS. So they are
Ultrasound Examination is Important for Monochorionic Twins
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Pump twin
Acardiac
twin
Fig. 3. Grossly malformed acardiac twin and normal struc-
ture pump twin.
Fig. 4. Umbilical flow at the acardiac; the umbilical artery is
pumping into the acardiac twin.
usually recognized as TTTS in the first impression.
About 25% of cases transferred to the Florida Insti-
tute for Fetal Diagnosis and Therapy with a sus-
pected diagnosis of TTTS later turned out not to
fulfill the TTTS criteria. Those cases varied from sim-
ple amniotic fluid volume discordance to isolated
polyhydramnios and isolated oligohydramnios [6].
Since September 2005, there were about 16 cases
transferred to Chang Gung Memorial Hospital,
Linkou Medical Center under the impression of
TTTS, four of the 16 cases were MC twins with selec-
tive IUGR, one of the four cases eventually met the
criteria for TTTS after 2 weeks.
The main pathophysiologic basis of MC twins
with selective IUGR is the territory factor; it arises
from unequal sharing of the placenta in MC twins.
It differs from the vascular communicating factor
in TTTS.
The diagnosis of MC twins with selective IUGR
in ultrasound is:
1. MC placenta;
2. IUGR of the small twin, estimated fetal weight
below the 10th percentile in one twin of MC
pregnancy;
3. Lack of polyhydramnios/oligohydramnios sequel.
They can present as oligohydramnios in the small
twin but lack polyhydramnios in the appropriate for
gestational age (AGA) twin, or polyhydramnios in
the AGA twin but lack oligohydramnios in the
small twin.
Selective IUGR occurs in about 12% of twin preg-
nancies [28]. The incidence of this process is similar
in dichorionic (DC) and MC twin pregnancies, but
the risk of neurologic damage may be greater in MC
twins [29]. Spontaneous demise of the twin with
selective IUGR may result in the concomitant demise
of the twin who is AGA in up to 40% of cases or in
neurologic damage of the AGA twin in up to 30% of
cases [27]. However, even in the absence of single
intrauterine fetal death, the risk of neurologic dam-
age may be increased in MC as compared with DC
twin pregnancies [29].
Current treatment of selective IUGR in MC
twins involves expectant management and early
delivery (if warranted), termination of pregnancy,
or umbilical cord occlusion [27]. The prognosis of
MC twins with selective IUGR is highly influenced
by the umbilical artery Doppler of the small twin. If
the small twin suffers from absence or reversal of
end-diastolic velocity of the umbilical artery, it
would display a relatively high perinatal mortality
rate. Quintero et al [27] conducted a pioneer
study using laser therapy to convert the MC pla-
centa to a functionally DC one. They claimed that
the neurologic deficit in the IUGR twin would
decrease but the mortality rate of the small twin
would remain the same. The technique to laser the
communicating vessels in MC twins with selective
IUGR is more difficult than in TTTS usually because
of the lack of polyhydramios. In unfamiliar hands,
it could make the condition worse.
Congenital Malformations in Twins
The incidence of malformations in twins varies by
chorionicity. The overall risk of congenital malforma-
tion in twins is 600/10,000 twin births. Monozygotic
twinning is associated with midline defects such as
holoprosencephaly, neural tube defects, and cloaca
extrophy [3]. Overall, MC twins have a two- to
three-fold higher rate than DC twins [3]. In a con-
genital anomaly that is lethal, fetocide is unnecessary
except unless polyhydramnios or TTTS occurs, and
expectant management is the sensible option.
For example, in anencephaly, if fetocide is con-
sidered, bipolar cord occlusion is the choice because
potassium chloride injection is not feasible due to
the communicating vessels that almost always
exist between the two twins. The bipolar could be
inserted into the uterus via a 2.5–3.5 mm trocar.
Cord insertion near the fetus is better than near
the placenta to be coagulated to prevent throm-
bosis or thermo damage to another twin.
Conclusion
Sonography has made a dramatic impact on the
obstetric diagnosis and management of complicated
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MC twin pregnancies [30]. Since these relatively rare
complications are unique to MC twins, obstetri-
cians, especially those dedicated to high-risk preg-
nancies, should be familiar with the diagnosis. The
management of such complications should be left
in expert hands.
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